“Human Papilloma virus immunization is cost effective if immunity is life-long, and if all 12-year old girls are immunized (in the USA)”, Rev Port Med Geral Fam, vol. 24, no. 5, pp. 641–2, Sep. 2008, doi: 10.32385/rpmgf.v24i5.10555.